Climb Bio Inc Cash Flow Reinvestment Rate
Latest as of September 2023:
8.03x
Climb Bio Inc cash flow reinvestment rate. Climb Bio Inc (CLYM) has a Cash Flow Reinvestment Rate of 8.03x as of September 2023, reinvesting $28.04 Million (capex $0.00 plus investments $28.04 Million) from operating cash flow of $3.49 Million. Explore Climb Bio Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
8.03x
(Capex + Investments) / Operating CF
Total Reinvested
$28.04 Million
Capex + Investments
Operating Cash Flow
$3.49 Million
USD
Capital Expenditures
$0.00
USD
Climb Bio Inc Cash Flow Reinvestment Rate by Year (None–None)
Climb Bio Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Climb Bio Inc. For the full cash flow conversion analysis, see Climb Bio Inc cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow